Palatin Technologies

Palatin Technologies (AMEX:PTN) is a biopharmaceutical company primarily focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin (“MC”)-based therapeutics. Therapeutics affecting the activity of the MC family of receptors may have the potential to treat a variety of conditions and diseases, including sexual dysfunction, obesity and related disorders, cachexia (extreme wasting, generally secondary to a chronic disease), skin pigmentation and inflammation. The Company is exploring other receptor-specific therapeutics, including congestive heart failure therapeutics, using its patented drug discovery platform. Palatin has entered into collaborations with industry leaders AstraZeneca, King Pharmaceuticals (NYSE:KG) and Mallinckrodt Imaging, a subsidiary of Tyco Healthcare (NYSE: TYC).

Contact Details: 4-C Cedar Brook Drive Cedar Brook Corporate Center Cranbury NJ 08512 United States of America Tel: 1-609-495-2200 Fax: 1-609-495-2201 Email: investors@palatin.com WWW: www.palatin.com/

Loading...

Recent Publications by Palatin Technologies:
Melanocortins in the treatment of male and female sexual dysfunction. Melanocortinergic agents are currently being investigated for a possible...	25th September, 2007	Palatin Technologies,	Curr Top Med Chem. 2007;7(11):1137-44.
An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. INTRODUCTION: Melanocortins affect multiple physiological responses,...	18th October, 2006	Palatin Technologies, Inc., Cranbury, NJ 08512, USA.	J Sex Med. 2006 Jul;3(4):628-38. DOI Direct Link
Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. OBJECTIVES: To evaluate the safety and pharmacodynamic effect of...	13th December, 2005	Palatin Technologies, Inc., Cranbury, New Jersey 08512, USA.	Urology. 2005 Apr;65(4):755-9. DOI Direct Link
PT-141: a melanocortin agonist for the treatment of sexual dysfunction. PT-141, a synthetic peptide analogue of alpha-MSH, is an agonist at...	30th August, 2003	Palatin Technologies, Inc, Cranbury, New Jersey 08512, USA.	Ann N Y Acad Sci. 2003 Jun;994:96-102.

BioNews Results for Palatin Technologies:
Palatin Technologies to Report Fourth Quarter and Fiscal Year End 2008 Financial Results; Conference Call and	SmartBrief:  Sep 28 2008 8:59PM Matching: palatin technologies
Palatin Technologies to Report Fourth Quarter and Fiscal Year End 2008 Financial Results; Conference Call and	KSLA:  Sep 25 2008 11:58AM Matching: palatin technologies
Palatin Technologies to Report Fourth Quarter and Fiscal Year End 2008 Financial Results; Conference Call and	Pharma Live:  Sep 25 2008 8:13PM Matching: palatin technologies
Palatin Technologies to Report Fourth Quarter and Fiscal Year End 2008 Financial Results; Conference Call and	KOTA Territory News:  Sep 25 2008 5:29PM Matching: palatin technologies
Preclinical services news in brief	Outsourcing Pharma:  Sep 25 2008 12:31AM Matching: palatin technologies
Promote your company here: BioNewsCast - Press Release Distribution	→View more Palatin Technologies news.

Palatin Technologies Patents:
US Patent No.	Title
7425608	Method of making metallopeptides
6579968	Compositions and methods for treatment of sexual dysfunction
6794489	Compositions and methods for treatment of sexual dysfunction
6979436	Opioid metallopeptide compositions and methods
7049398	Melanocortin metallopeptide constructs, combinatorial libraries and applications
→View more Palatin Technologies patents.

Palatin Technologies (PTN) Financial information Links from Barchart
PTN Quote from from Barchart.com
PTN Chart from from Barchart.com
PTN Profile from from Barchart.com
PTN Opinion from from Barchart.com
→View more Palatin Technologies finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 174 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: PL-3994 | palatin technologies | .

Search for more companies in Cranbury

Search for more companies in NJ

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Palatin Technologies